当前位置: X-MOL 学术Leukemia › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
High-dose methotrexate therapy significantly improved survival of adult acute lymphoblastic leukemia: A phase III study by JALSG
Leukemia ( IF 12.8 ) Pub Date :  , DOI: 10.1038/leu.2017.283
T Sakura , , F Hayakawa , I Sugiura , T Murayama , K Imai , N Usui , S Fujisawa , T Yamauchi , T Yujiri , K Kakihana , Y Ito , H Kanamori , Y Ueda , Y Miyata , M Kurokawa , N Asou , K Ohnishi , S Ohtake , Y Kobayashi , K Matsuo , H Kiyoi , Y Miyazaki , T Naoe

High-dose methotrexate therapy significantly improved survival of adult acute lymphoblastic leukemia: A phase III study by JALSG

Leukemia, Published online: 15 September 2017; doi:10.1038/leu.2017.283



中文翻译:

大剂量甲氨蝶呤疗法可显着提高成人急性​​淋巴细胞白血病的存活率:JALSG的一项III期研究

大剂量甲氨蝶呤疗法可显着提高成人急性​​淋巴细胞白血病的存活率:JALSG的一项III期研究

白血病,在线发布:2017年9月15日; doi:10.1038 / leu.2017.283

更新日期:2017-09-15
down
wechat
bug